{
    "code": "02023955",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023955",
    "time": "2016-11-18 20:26:41",
    "許可證字號": "衛署藥輸字第023955號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/05\/30",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "103\/04\/13",
    "發證日期": "93\/04\/13",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202395503",
    "中文品名": "鹽酸希提瑞立",
    "英文品名": "CETIRIZINE DIHYDROCHLORIDE",
    "適應症": "抗組織胺劑。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        "CETIRIZINEDIHYDROCHLORIDE(EQTOCETIRIZINE2HCL)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0400319100  中大藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200120000  MATRIX LABORATORIES LIMITED",
        "製造廠廠址": "UNIT-7, PLOT NO.14 99 &amp; 100, IDA PASHAMYLARAM PHASE-II, PATANCHERU, MEDAK DISTRICT, ANDHRA PRADESH, INDIA",
        "製造廠公司地址": "1-1-151\/1, IV FLOOR, SAIRAM TOWERS ALEXANDER ROAD, SECUNDERABAD-500 003 INDIA",
        "": ""
    },
    "CCC號列": "29335990900 其他之結構中含嘧啶環（不論是否氫化）或六氫？？環之化合物Other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400005810",
            "成分名稱": "CETIRIZINE DIHYDROCHLORIDE (EQ TO CETIRIZINE 2HCL )",
            "含量描述": "(99.0-100.5)",
            "含量": "",
            "單位": "%"
        }
    ]
}